Thursday, February 16, 2012

10:45-11:15

Top tips for chairs (Closed session)

Geert D’Haens, Amsterdam, The Netherlands

11:30-12:30

Satellite symposium 1a & 1b 

12:45-13:00

Opening &   welcome

Miquel Gassull, Barcelona, Spain

Daniel Hommes, Los Angeles, United States

13:00-14:20

Scientific session 1: Common ground across inflammatory disorders

Miquel   Sans, Barcelona, Spain

Jan   Wehcamp, Stuttgart, Germany

13:00-13:30

Tandem talk: Shared pathways in inflammation

Maria Abreu, Miami, United States

Fiona Powrie, Oxford, United Kingdom

13:30-13:40

Best abstract: Card9 is a crucial adapter protein for gastrointestinal immune response
Harry Sokol, Paris, France

13:40-13:50

Best abstract: Identification of glycoprotein 2 as an immunomodulator of innate and adaptive immune responses
Lael Werner, Berlin, Germany

13:50-14:00

Best abstract: Induction of autophagy upon DC-T cell contact is mediated by LKB1-AMPK-mTOR signalling
Manon Wildenberg, Amsterdam, The Netherlands

14:00-14:20

Inflammatory side-effects of biological therapy

François Aubin, Besançon, France

14:20-14:50

Coffee break

14:50-16:10

Scientific session 2: Measuring success and failure in IBD

Dana   Duricova, Prague, Czech Republic

Pierre   Michetti, Lausanne Switzerland

14:50-15:10

Predicting disease outcome

Siew Ng, Hong Kong, China

15:10-15:20

Best abstract: Mortality and cancer in paediatric Inflammatory Bowel Disease: A population-based study
Guillaume Savoye, Rouen, France

15:20-15:40

Tandem talk: Scoring disease damage and disability

Benjamin Pariente, Paris, France

Laurent Peyrin-Biroulet, Vandœuvre-lès-Nancy, France

15:40-15:50

Best abstract: Development of three practical indices for mucosal healing among patients with moderate to severe Crohn's Disease
Edouard Louis, Liège, Belgium

15:50-16:10

Assessing endoscopic and disease activity in practice

Gert van Assche, Leuven, Belgium

16:10-16:30

Scientific session 3: Preliminary results from the 3^rd Scientific Workshop

Dana   Duricova, Prague, Czech Republic

Pierre   Michetti, Lausanne Switzerland

16:10-16:30

Malignancy in IBD

Silvio Danese, Milan, Italy

Laurence Egan, Galway, Ireland

Laurent Beaugerie, Paris, France

16:30-17:00

Mini-session 3: ECCO-ESPGHAN Paediatric Guidelines on UC

Dan   Turner, Jerusalem, Israel

17:15-18:15

Satellite symposium 2a

Friday, February 17, 2012

07:15-08:15

Satellite symposium 3b

08:30-09:30

Scientific Session 4: Imaging in IBD

Andre D’Hoore, Leuven,   Belgium

Simon Jackson,   Plymouth, United Kingdom

Janneke Van der Woude,   Rotterdam, The Netherlands

08:30-08:35

Medical or surgical therapy for obstruction: Is imaging the key?

Casper Gijsbert Noomen, Amsterdam, The Netherlands

08:35-08:40

IBD facing surgery - Are you sure the small bowel is normal?

Ailsa Hart, London, United Kingdom

08:40-09:00

ECCO-ESGAR Imaging Guidelines

Julian Panes, Barcelona, Spain

09:00-09:10

Case resolution

09:10-09:20

Best abstract: Endocytoscopy allows accurate in vivo differentiation of mucosal inflammatory cells in IBD - A pilot study
Helmut Neumann, Erlangen, Germany

09:20-09:30

Best abstract: Use of fecal calprotectin as marker of disease activity in patients under maintenance treatment with Infliximab for Ulcerative Colitis
Martine De Vos, Gent, Belgium

09:30-10:30

Scientific session 5: Complications carousel: Management tips and tricks

Andre D’Hoore, Leuven,   Belgium

Simon Jackson,   Plymouth, United Kingdom

Janneke Van der Woude,   Rotterdam, The Netherlands

09:30-09:37

Anaemia

Christoph Gasche, Vienna, Austria

09:37-09:44

Osteoporosis

Ad Van Bodegraven, Amsterdam, The Netherlands

09:44-09:51

Renal

Satish Keshav, Oxford, United Kingdom

09:51-09:58

Ocular

Luis Pablo, Zaragoza, Spain

09:58-10:05

Pulmonary

Franck Carbonnel, Besançon, France

10:05-10:12

Thromboembolism

Gerassimos Mantzaris, Athens, Greece

10:12-10:30

Discussion

10:30-11:00

Coffee break

11:00-12:20

Scientific session 6: Impact of IBD on daily life

Fernando   Magro, Porto, Portugal

Fermin   Mearin, Barcelona, Spain

11:00-11:40

Debate: IBD and IBS - Marriage or divorce?

Michael Kamm, Melbourne, Australia

Giovanni Barbara, Bologna, Italy

11:40-11:50

Best abstract: SPARC modifies colonic tissue healing and inflammation by regulating collagen and MMP expression
Ian Lawrance, Fremantle, Australia

11:50-12:00

Best abstract: Anti-TNF-α therapy is a major cost driver in Inflammatory Bowel Disease: Results from the COIN study
Utrecht, The Netherlands

12:00-12:20

The patient perspective

Ben Wilson, Newcastle, United Kingdom

12:20-13:15

Lunch and guided poster session in the exhibition hall

13:15-13:30

Poster award ceremony

13:30-14:30

Scientific session 7: Organising care in IBD

Francesc   Casellas, Barcelona, Spain
Mircea   Diculescu, Bucharest, Romania

13:30-13:50

E-Health and home-testing: Ready for prime time?

Pia Munkholm, Copenhagen, Denmark

13:50-14:00

Best abstract: Importance of trough levels and antibodies on the long-term efficacy of infliximab therapy in Ulcerative Colitis
Maria Teresa Arias, Santander, Spain

14:00-14:10

Best abstract: Individualised infliximab treatment using therapeutic drug monitoring: A prospective controlled trough level adapted infliximab treatment (TAXIT) trial
Niels Vande Casteele, Leuven, Belgium

14:10-14:30

The IBD care pathway

Daniel Hommes, Los Angeles, United States

14:30-15:00

Coffee break

15:00-15:50

Scientific session 8: ECCO Fellowships and Grants

Andreas   Sturm, Berlin, Germany

15:00-15:05

Fellowship 1

Bénédicte Brounais-Le Royer, Geneva, Switzerland

15:05-15:10

Fellowship 2

Lael Werner, Berlin, Germany

15:10-15:20 

Announcement of ECCO   Fellowships and Grants 2012

Andreas Sturm, Berlin, Germany

15:20-15:30

  Role of proteases in IBD
  Daniel Lottaz, Bern, Switzerland

15:30-15:40

Best abstract: Multiple functional variants at the 3p21 locus contribute to Ulcerative Colitis: Results from a European consortium
Isabelle Cleynen, Leuven, Belgium

15:40-15:50

Best abstract: TLR4 signaling activates the WNT pathway in a mouse model of colitis-associated neoplasia
Rebeca Santaolalla, Miami, United States

15:50-17:25

Scientific session 9: Challenging Cases

Manuel Barreiro, Santiago de Compostela, Spain

Peter Irving, London, United Kingdom

Jürgen Schölmerich, Frankfurt am Main, Germany

Antonino Spinelli, Milan, Italy

15:50-16:10

Case 1: Avoiding complications in patients with anti-TNF treatment

Xavier Aldeguer, Girona, Spain

16:10-16:30

Case 2: The troubled journey of a young colitis patient
Shaji Sebastian, Hull, United Kingdom

16:30-16:50

Case 3: Timing of surgery with anti-TNF therapy
Paulo Kotze, Curitiba, Brazil

16:50-17:00

Best abstract: Adenomas in patients with Inflammatory Bowel Disease: Increased risk of advanced neoplasia
Fiona van Schaik, Utrecht, The Netherlands

17:00-17:10

Best abstract: Immunosuppressive co-treatment with adalimumab (ADA) may be more effective than ADA monotherapy for maintaining remission in Crohn's Disease (CD)
Catherine Reenaers, Liège, Belgium

17:10-17:25

How I manage abnormal   LFTs in IBD

Maria Esteve, Barcelona, Spain

17:40-18:40

Satellite symposium 4a

20:00

ECCO Interaction: Hearts and Minds

Saturday, February 18,   2012

07:15-08:15

Satellite symposium 5b

08:30-10:00

Scientific session 10: Surgery in IBD

Daniel   Hommes, Los Angeles, United States

Bjourn   Moum, Oslo, Norway

08:30-08:50

Perianal CD

Bruce George, Oxford, United Kingdom

08:50-09:00

Best abstract: Adding ciprofloxacin to adalimumab results in a higher fistula closure rate in perianal fistulizing Crohn's Disease
Peter Dewint, Rotterdam, The Netherlands

09:00-09:20

Tandem talk: Find the best timing for surgery

Sandro Ardizzone, Milan, Italy

Antonino Spinelli, Milan, Italy

09:20-09:30

Best abstract: Risk of colectomy in patients with Ulcerative Colitis under thiopurine treatment. Study of prevalence and predictive factors. ENEIDA project
Alex Canas-Ventura, Barcelona, Spain

09:30-09:40

Best abstract: Long-term outcome after first intestinal resection in paediatric-onset Crohn's Disease: A population-based study
Median Boualit, Lille, France

09:40-10:00

Managing complications

Emmanuel Tiret, Paris, France

10:00-10:30

Coffee break

10:30-11:50

Scientific session 11: Where are we heading?
Antonio   Lopez San Roman, Madrid, Spain

Simon   Travis, Oxford, United Kingdom

10:30-10:50

Are gene hunting days over?

Miles Parkes, Cambridge, United Kingdom

10:50-11:00

Best abstract: Genetic and functional evidence for a role for CYLD in Crohn's Disease: Results from a European consortium
Isabelle Cleynen, Leuven, Belgium

11:00-11:20

Are stem cells ready for clinical practice?

Gijs Van der Brink,   Amsterdam, The Netherlands

11:20-11:30

Best abstract: TNF and MDP induce epithelial-to-mesenchymal transition in human intestinal cells: Implications for the pathogenesis of Crohn's Disease-associated fistulae and the use of anti-TNF antibodies
Michael Scharl, Zurich, Switzerland

11:30-11:50

Are we ready to manage the microbiome?

Arlette Darfeuille-Michaud, Clermont-Ferrant, France

11:50-12:20

Scientific session 12: ECCO Lecture
Antonio   Lopez San Roman, Madrid, Spain

Simon   Travis, Oxford, United Kingdom

11:50-12:20

Translating evidence from clinical trials into personalised medicine

Stephen Hanauer, Chicago, United States

12:20-12:30

Closing remarks

Simon Travis, Oxford, United Kingdom